Award Year / Program / Phase:1997 / SBIR / Phase I
Agency / Branch:DOD / DARPA
Principal Investigator:John Pace
Award Amount:$98,400.00
Abstract:
Acute infectious diseases pose significant problems which include the potential failure of antimicrobial therapy and the serious sequelae that may result. These treatment failures may occur due to a lack of diagnostic information during early onset of the disease, resulting in the use of the… More
Antex biologics is developing inactivated whole cell vaccines for oral delivery to prevent infections by bacteria causing traveler's diarrhea. A new, possibly breakthrough, microbead formulation technology is being developed which should be evaluated forits potential to enhance these inactivated… More